As healthcare providers turn their attention to resuming elective surgeries and procedures, it is important that this entry into the “new normal” be undertaken with care. Health care governing boards have an essential fiduciary oversight role in this process.
On June 15, 2020, the owner of several information technology companies was charged in a criminal complaint with bank fraud and for making false statements to a financial institution.
The 2020 edition of Legal 500 US has rated 43 Arent Fox LLP attorneys as national leaders in their field. In addition, 14 of the firm’s practice areas were ranked among the best in the country.
Health Care partner Thomas Jeffry was recently quoted in a Healthcare Risk Management article titled “COVID-19 Changes HIPAA Compliance, But Caution Necessary.”
Join Jeff Blake, Managing Partner of Federal Compliance Solutions, and Stephanie Trunk, Health Care Partner at Arent Fox, for a Government Pricing & Pharmaceutical Reimbursement Office Hour.
Health Care Partner Anne Murphy was recently quoted by Bloomberg Law in an article titled “Hospitals Walk Legal Tightrope as Workers Speak Out on Virus.”
Accredited organizations should begin to prepare for the resumption of survey activity in a modified form. Organizations that are experiencing a COVID-19 surge or have other challenges may want to reach out to the accrediting organization to discuss the impact of survey activity at this time.
A HHS Final Rule for Exchange plans states that coupons and copay cards offered directly by drug manufacturers can be counted towards a patient’s annual cost-sharing limit.
Rachel Hold-Weiss will present during the 2020 American Health Law Association’s (AHLA) Annual Meeting. Rachel’s presentation “Hindsight is 2020: A Look at Home Health and Hospice in the New Decade,” focuses on compliance and regulatory issues for home health and hospice providers.
In what has been considered a huge win for community pharmacists, the Department of Health and Human Services (HHS) Office of the General Counsel (OGC) issued an Advisory Opinion on May 19, 2020.
On May 12, the California Department of Consumer Affairs (DCA) issued an Order Waiving Restrictions on Pharmacists Ordering and Collecting Specimens for COVID-19 Tests, under the authority of California Governor Newsom’s March 30 Executive Order.
Stephanie Trunk will present during the ABA International Law Section’s 2020 virtual annual meeting. She will discuss how different jurisdictions address consumers’ demand for affordability of prescription drug and medical devices.
The National Practitioner Data Bank (NPDB) recently confirmed that the deadlines for reporting adverse actions against licensees have not been extended, despite the COVID-19 emergency.
DCA’s Order Waiving Postgraduate Training License Deadline, effective as of May 6 under the authority of California Governor Newsom’s March 30 Executive Order, is the latest in a series of healthcare licensing waivers issued since March 31.